Cosentyx Continues to Ease Symptoms Through 3 Years of Use, New Trial Data Show
Treatment with Cosentyx (secukinumab) continues to be safe and to ease symptoms in people with active ankylosing spondylitis (AS) through three ... Read more
Updates
-
-
Altered Gut Microbiome Contributes to Inflammation in Ankylosing Spondylitis, Study Suggests
People with ankylosing spondylitis (AS) have an altered composition of microorganisms in their gut, leading to more bacteria that play a role in ... Read more -
The Importance of Meeting Other People with Ankylosing Spondylitis
I rarely meet anyone with ankylosing spondylitis (AS), and I almost never meet someone who knows what it is or how to pronounce ... Read more -
Health Canada Approves Cimzia for Non-radiographic Axial Spondyloarthritis
Health Canada has approved Cimzia (certolizumab pegol) for the treatment of adults with severe active non-radiographic axial spondyloarthritis (nr-axSpA). The medication is ... Read more -
Qletli, Biosimilar to Humira, Now Available in China to Treat Certain Autoimmune Diseases
Qletli, a biosimilar to Humira (adalimumab), is now available in China for the treatment of three autoimmune diseases, including ankylosing spondylitis (AS). The ... Read more
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
-
As a New Year Begins, I’m Seeking the Silver Lining with AS
As we begin a new decade and a new year, I’m trying to focus ... -
Levels of DNASE1L3 Protein Are Potential Biomarker of Ankylosing Spondylitis, Study Suggests
Analyzing the levels of a protein called DNASE1L3 may enable an accurate diagnosis of ... -
Mabpharm Seeks Approval of Infliximab Biobetter in China
Mabpharm has filed an application with China’s National Medical Products Administration (NMPA) seeking approval ... -
Reflecting on My Past Year with Ankylosing Spondylitis
The past year has been good for me in terms of my ankylosing spondylitis. ... -
nr-axSpA Patients Less Likely to be Treated With Biologics Than Those With Ankylosing Spondylitis, US Survey Shows
Despite experiencing similar symptoms, people with non-radiographic axial spondyloarthritis (nr-axSpA) are less likely to ... -
First Patient Dosed in Phase 3 Trial in China Testing Enbrel Biosimilar SCB-808
The first ankylosing spondylitis (AS) patient has been dosed in a Phase 3 trial testing ...
Cosentyx Leads to Long-Term Improvement in AS Patients, Phase 3 Trial Shows
News
Results from a Phase 3 clinical trial show that treatment with Cosentyx (secukinumab) led to fast, significant, and sustained symptom improvement in patients with active ankylosing spondylitis (AS). Improvements were particularly noticeable in patients who had never ... Read more